Powder: -20°C for 3 years | In solvent: -80°C for 1 year
J30-8, a potent and isoform-selective c-Jun N-terminal kinase 3 (JNK3) inhibitor with an IC50 of 40 nM and 2500-fold isoform selectivity against JNK1α1 and JNK2α2, exhibits neuroprotective activity in vitro and shows promise for treating neurodegenerative diseases.
Description | J30-8, a potent and isoform-selective c-Jun N-terminal kinase 3 (JNK3) inhibitor with an IC50 of 40 nM and 2500-fold isoform selectivity against JNK1α1 and JNK2α2, exhibits neuroprotective activity in vitro and shows promise for treating neurodegenerative diseases. |
Targets&IC50 | JNK3:40 nM |
Molecular Weight | 373.79 |
Formula | C17H9ClFN3O2S |
CAS No. | 2366255-71-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
J30-8 2366255-71-0 Others J-30-8 J308 J30 8 inhibitor inhibit